The U.S. Food and Drug Administration (FDA) announced Wednesday that it will relax certain rules for approving low-cost versions of some high-priced medications, in an effort to speed up access to ...
(n){if(!window.cnxel){window.cnxel={},window.cnxel.cmd=[];var t=n.createElement('iframe');t.src='javascript:false'; t.display='none',t.onload=function(){var ...
Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.
California has launched a program to manufacture and sell lower-cost insulin to people with diabetes. State officials say consumers will be able to purchase a five-pack of insulin pens for $55 in ...
Biocon Biologics recently announced that it would manufacture and supply insulin glargine pens to Civica under a multi-year ...
Our Bureau, Bengaluru Monday, October 20, 2025, 15:20 Hrs [IST] Biocon Biologics, a global leader in biosimilars and the world ...
Hosted on MSN
California to offer generic insulin for $11 per vile
California to offer generic insulin for $11 per vile Tropical Storm Melissa update as "catastrophic" conditions to hit in hours ICE, CBP seize 400 firearms hidden in fake trailer walls at southern ...
SACRAMENTO, California — California will start selling low-cost insulin in January, becoming the first state in the nation to bypass Big Pharma with its own supply of the expensive diabetes drug and ...
BRIDGEWATER, N.J. and BENGALURU, India, Oct. 16, 2025 /PRNewswire/ -- Biocon Biologics Ltd. (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd. (BSE code: 532523, NSE: ...
WASHINGTON — President Trump posted a video Tuesday afternoon showing the US military bombing another alleged Venezuelan drug boat, killing its six occupants. “Under my Standing Authorities as ...
Share on Pinterest The FDA recently approved a generic abortion pill that’s considered as safe and effective as mifepristone. Shuran Huang for The Washington Post via Getty Images The approval, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback